Efficacy and Safety of Frontline Treatment Options for ALK+ NSCLC
November 30th 2021Karen Reckamp, MD, and Jyoti Patel, MD, review currently available frontline treatment options for ALK+ advanced NSCLC and discuss updated efficacy and safety data from key clinical trials of these agents in advanced NSCLC.
Hot Topics With Immunotherapy in Lung Cancer
September 7th 2018Karen Reckamp, MD, co-director of the Thoracic Oncology Program at the City of Hope Comprehensive Cancer Center, discusses combinations with immunotherapy in lung cancer at the International Lung Cancer Congress. She says this is a very hot topic in the field right now.